METHOD OF PRODUCING A PERIPHERAL BLOOD MONONUCLEAR CELL COMPOSITION SUITABLE FOR REPAIRING OR ENGINEERING A TISSUE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 15, 2024
app pub date -
Mar 14, 2024
filing date -
Nov 23, 2011
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Disclosed is a method of in vitro fertilization wherein the embryo is implanted into the uterus of a female patient at least two, an preferably three to twelve months after the eggs are retrieved from the patient in order to reduce the effect of autoimmune rejection of the embryo by the patient's autoimmune system and increase the probability and success of pregnancy and wherein prior to embryo implantation, the endometrium in the uterus is prepared for embryo implantation by introducing peripheral blood mononuclear cells (PBMCs) into the uterus. The procedure is combined with cryopreservation techniques to preserve the oocytes or the IVF-produced embryos of the patient.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully